# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Truist Securities analyst Samuel Brodovsky maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target f...
Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $37 to $42.
JMP Securities analyst David Turkaly reiterates OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and maintains $50 pri...
OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.4...
OrthoPediatrics Corp. ("OrthoPediatrics") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediat...
Needham analyst Mike Matson reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $37 price target.